Ultragenyx to Present at the 11th Annual Biotechnology Industry Organization (BIO) Investor Forum in San Francisco

NOVATO, Calif., Oct. 3, 2012 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc., a biotechnology company, today announced that Emil D. Kakkis, M.D., Ph.D, the company's CEO, will be presenting at the 11th Annual BIO Investor Forum on October 10, 2012 at 9:00am Pacific Time at the Palace Hotel in San Francisco, CA. The presentation will be held in the Pacific Heights conference room. Dr. Kakkis will also be participating as a panelist on the Therapeutic Workshop, "Raring to Go: The Race to Treat Ultra-Rare Disease", being held from 2:00-2:55pm in the Twin Peaks conference room.